DOC
Healthpeak Properties, Inc.
$21.65
+0.08 (+0.37%)
At close · Jul 10
Market Cap
$14.94B
Shares
689,419,702
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.82B
+4.5%
FY2025
Net Income
$71.35M
-70.7%
FY2025
Gross Margin
60.2%
+1.6pp
FY2024
Diluted EPS
$0.10
-72.2%
FY2025
Operating Cash Flow
$1.25B
+17%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.87B | $2.82B | $2.7B | $2.18B | $2.06B | $1.9B | $1.64B | $1.24B | $1.19B | $1.85B | $2.13B | $1.94B | $1.64B | $2.1B | $1.88B | $1.69B | $1.24B | $1.15B | $1.14B | $945.81M | |
| $2.16B | $2.16B | $2.09B | $1.63B | $1.54B | $1.38B | $1.18B | $1.07B | $1.02B | $1.21B | $1.16B | $1.12B | $1.15B | $1.13B | $997.77M | $986.43M | $904.33M | $875.78M | $867.37M | $751.88M | |
| $1.12B | — | $1.07B | $902.06M | $862.99M | $773.28M | $782.54M | $405.24M | $378.66M | $666.25M | $738.4M | — | — | — | — | — | — | — | — | — | |
| $1.68B | — | $1.63B | $1.28B | $1.2B | $1.12B | $862.33M | $835.1M | $812.66M | $1.18B | $1.39B | — | — | — | — | — | — | — | — | — | |
| — | — | 60.2% | 58.64% | 58.13% | 59.22% | 52.43% | 67.33% | 68.22% | 63.95% | 65.32% | — | — | — | — | — | — | — | — | — | |
| $88.89M | $90.42M | $97.16M | $95.13M | $131.03M | $98.3M | $93.24M | $92.97M | $96.7M | $88.77M | $103.61M | $95.97M | $81.77M | $103.04M | $68.41M | $96.06M | $83.02M | $77.9M | $73.69M | $67.5M | |
| $1.08B | $1.06B | $1.06B | $749.9M | $710.57M | $684.29M | $553.95M | $435.19M | $404.68M | $534.73M | $568.11M | $504.91M | $455.02M | $423.31M | $353.7M | $346.06M | $306.93M | $315.74M | $312.01M | $257.01M | |
| $0 | $0 | — | $0 | $0 | — | — | — | — | — | — | $3.12M | — | — | $7.88M | — | — | — | $1.57M | — | |
| $974.69M | — | — | $902.06M | $862.99M | $773.28M | $782.54M | $405.24M | $378.66M | $666.25M | $738.4M | $610.68M | $381.29M | $298.28M | — | — | — | — | — | — | |
| $2.71B | $2.61B | $2.67B | $1.96B | $1.89B | $1.74B | $1.71B | $1.17B | $1.15B | $1.77B | $1.88B | $1.83B | $1.37B | $1.27B | $1.14B | $1.22B | $873.72M | $1.05B | $945.26M | $855.41M | |
| $319.78M | $305.18M | $280.43M | $200.33M | $172.94M | $157.98M | $218.34M | $217.61M | $261.28M | $307.72M | $464.4M | $479.6M | $439.74M | $435.25M | $416.17M | $415.46M | $285.51M | $298.6M | $348.34M | $355.2M | |
| $266.14M | $69.97M | $238.04M | $93.27M | $335.35M | -$28.97M | $282.12M | $106.67M | $800.63M | $333.83M | $122.33M | $22.59M | $12.54M | $18.22M | $2.98M | $12.93M | $16.19M | $7.77M | $25.67M | $34.53M | |
| -$167.57M | -$173.98M | -$1.52M | $10.2M | $1.99M | $6.1M | -$66.6M | -$6.33M | -$5.76M | $10.9M | $11.36M | $6.59M | $49.57M | $64.43M | $54.46M | $46.75M | $4.77M | $3.51M | $3.33M | $5.65M | |
| — | — | — | — | — | — | — | — | — | — | — | — | $2.27M | $10.82M | -$43K | -$5.4M | $14.6M | $8.88M | -$7.23M | $2.23M | |
| $425.65M | $284.29M | $273.17M | $314.94M | $507.13M | $128.37M | $217.68M | -$8.63M | -$2.59M | $10.9M | $11.36M | $6.59M | -$3.61M | $852.02M | $745.08M | $490.68M | $382.68M | $101.06M | $225.4M | $124.93M | |
| $7.46M | $9.28M | $4.35M | -$9.62M | -$4.43M | -$3.26M | -$9.42M | -$5.48M | -$4.4M | -$1.33M | $4.47M | -$9.81M | -$506K | $5.82M | -$1.65M | $1.3M | $412K | $1.91M | $4.22M | $1.44M | |
| $222.15M | $71.35M | $243.14M | $306.01M | $500.45M | $505.54M | $413.56M | $45.53M | $1.06B | $414.17M | $627.75M | -$559.24M | $922.23M | $970.84M | $832.54M | $538.89M | $330.71M | $131.69M | $448.5M | $589.02M | |
| — | 2.53% | 9% | 14.03% | 24.28% | 26.66% | 25.14% | 3.67% | 89.07% | 22.41% | 29.48% | -28.82% | 56.34% | 46.23% | 44.28% | 31.8% | 26.67% | 11.49% | 39.17% | 62.28% | |
| $14.68M | — | — | — | — | — | — | $14.53M | $12.38M | $8.47M | $12.18M | $12.82M | $14.36M | $14.17M | $14.3M | $15.6M | $13.69M | $14.46M | $22.49M | $25.1M | |
| $221.63M | $70.51M | $242.38M | $304.28M | $497.79M | $502.27M | $411.15M | $43.99M | $1.06B | $413.01M | $626.55M | -$560.55M | $919.8M | $969.1M | $812.29M | $515.3M | $307.5M | $109.07M | $425.37M | $565.08M | |
| $214.76M | $32.59M | $252.59M | $297.25M | $531.73M | $506.08M | $412.74M | $47.38M | $1.08B | $419.79M | $628.58M | -$565.81M | $912.83M | $971M | $837.47M | $532.55M | $319.61M | $210.72M | — | — | |
| USD/shares | — | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 | $0.77 | $0.09 | $2.25 | $0.88 | $1.34 | -$1.21 | $2.01 | $2.13 | $1.90 | $1.29 | $1.01 | $0.40 | $1.79 | $2.72 |
| USD/shares | — | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 | $0.77 | $0.09 | $2.24 | $0.88 | $1.34 | -$1.21 | $2.00 | $2.13 | $1.90 | $1.29 | $1.00 | $0.40 | $1.79 | $2.70 |
| shares | — | 696.03M | 675.68M | 547.01M | 538.81M | 538.93M | 530.56M | 486.26M | 470.55M | 468.76M | 467.2M | 462.8M | 458.43M | 455M | 427.05M | 398.45M | 305.57M | 274.22M | 237.3M | 207.92M |
| shares | — | 696.04M | 676.23M | 547.28M | 539.15M | 539.24M | 531.06M | 489.34M | 475.39M | 468.94M | 467.4M | 462.8M | 458.8M | 455.7M | 428.32M | 400.22M | 306.9M | 274.63M | 237.97M | 208.92M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $428.95M in buybacks, $14.09B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
67.72×
REIT - Healthcare Facilities median 33.41×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Outpatient Medical | $1,273,505,000 | $1,184,660,000 | $732,279,000 | $725,370,000 | $671,242,000 | — | — | — |
| Lab | $860,020,000 | $881,452,000 | $878,326,000 | $817,573,000 | $715,844,000 | — | — | — |
| Senior Housing | $603,989,000 | $568,475,000 | $527,417,000 | — | — | — | — | — |
| Lifescience | — | — | — | — | — | — | $440,784,000 | $395,064,000 |
| Medical Office | — | — | — | — | — | — | $571,530,000 | $547,375,000 |
| Senior Housing Operating Portfolio | — | — | — | — | — | — | $725,171,000 | $547,976,000 |
| Senior Housing Triple Net | — | — | — | — | — | — | $199,441,000 | $276,091,000 |
| CCRC | — | $568,475,000 | $527,417,000 | $494,935,000 | — | — | — | — |
| CCRC Segment | — | — | $527,417,000 | $494,935,000 | $471,325,000 | $436,494,000 | $3,010,000 | $0 |
| Lifescience | — | — | — | — | — | — | $440,784,000 | $395,064,000 |
| Life Science | — | — | — | $817,573,000 | — | $569,296,000 | — | — |
| Medical Office | — | — | — | $725,370,000 | — | $622,398,000 | $621,171,000 | $596,399,000 |
| Other Non-Reporting Segment | — | — | $21,781,000 | $23,300,000 | $37,773,000 | $16,687,000 | $175,374,000 | $199,857,000 |
| All Other Segments | — | — | — | — | — | — | $175,374,000 | $199,857,000 |
Key facts
CIK
765880
CUSIP
42250P103
13F (30d)
65 filings
36 filers
Visit website
Investor relations